Brief: Pure Biologics Gets Positive Results In Aptamer Study
17/08/2022 11:09
Aug 17 (Reuters) - Pure Biologics SA PUR1.WA :
* ACHIEVES POSITIVE RESULTS IN CONTRACTED RESEARCH
* COMPANY TO RECEIVE 0.2 MILLION ZLOTYS FOR RESEARCH
* RESEARCH REGARDS APTAMER
Source text for Eikon: ID:nEMbBk06va
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects